Case Report
TIO Associated with Hyperparathyroidism: A Rarity, a Rule, or a Novel HPT-PMT Syndrome—A Case Study with Literature Review
| Measure | Ref | 2011a | 2012a | 2013a | 2014a | 2015a | 2016a | 2017a | 2018b | 2019b | 2020b |
| PTH, pg/mL | 14–72 | 114.1 | — | 110.6 | 247.6 | 220.4 | — | 274.4 | — | — | 126.3 | Ca, mg/dL | 8.5–10.1 | 9.2 | 8.9 | 9.2 | 9.5 | 9.0 | 8.3 | 9.8 | 10.1 | 9.9 | 10.6 | PO4, mg/dL | 2.5–4.9 | 1.6 | 1.6 | 1.0 | 1.7 | 0.9 | 2.3 | 1.7 | 3.0 | 3.0 | 2.6 | Vit D 25(OH)D, ng/mL | 30–100 | 16 | — | 46 | 31 | 32 | — | 30 | 30 | 24 | 37 | Vit D 1,25(OH)2, pg/mL | 18–72 | 9 | — | 27 | - | 29 | — | 27 | 70 | 37 | - | ALP, IU/L | 44–174 | 283 | — | 252 | 243 | 262 | — | 103 | 71 | 71 | 71 | FGF23, RU/mL | 0–180 | — | — | 291 | - | - | — | 1330 | 160 | 174 | 174 | eGFR, mL/min/1.73 m2 | >60 | 58 | — | 85 | 90 | 75 | 66 | 64 | 66 | 66 | 61 | FeP | <20% | — | — | 44% | — | — | — | — | — | — | — |
|
|
ALP, alkaline phosphatase; Ca, calcium; eGFR, estimated glomerular filtration rate; FeP, fractional excretion of phosphate; FGF, fibroblast growth factor; PO4, phosphate; PTH, parathyroid hormone; Ref, reference. aPrior to tumor resection. bFollowing tumor resection.
|